PECULIARITIES AND CHARACTERISTICS OF INDICATORS OF THYROID CANCER AMONG RESIDENTS OF TOMSK AND TOMSK REGION
https://doi.org/10.20538/1682-0363-2014-2-74-81
Abstract
The analysis of thyroid cancer incidence and its structure among different populations of Tomsk region is presented. We studied the report documents, the database of the Tomsk regional oncologic dispensary for the period 2008 to 2012. The clinical characteristics of patients with thyroid cancer were summarizes according to sex, age and place of residence. The papillary cancer was the most often diagnosed. It was found that in young patients, thyroid cancer was diagnosed more often in the stage 1 and 2. On the other hand, in elderly patients (above 60 years), thyroid cancer diagnosed at stage 3 and 4. In the Tomsk region, as elsewhere in the world, thyroid cancer is detected more often in women.
About the Authors
I. N. Vorozhtsova
Siberian State Medical University, Tomsk
Russian Federation
Vorozhtsova Irina N.
Russian Federation
Vorozhtsova Irina N.
V. N. Latypova
Siberian State Medical University, Tomsk
Russian Federation
Latypova Venera N.
Russian Federation
Latypova Venera N.
T. V. Saprina
Siberian State Medical University, Tomsk
Russian Federation
Saprina Tatiana V.
Russian Federation
Saprina Tatiana V.
I. S. Beryozkina
Siberian State Medical University, Tomsk
Russian Federation
Beryozkina Irina S.
Russian Federation
Beryozkina Irina S.
A. P. Zima
Siberian State Medical University, Tomsk
Russian Federation
Zima Anastasiya P.
Russian Federation
Zima Anastasiya P.
A. I. Isaeva
Siberian State Medical University, Tomsk
Russian Federation
Isaeva Anna I.
Russian Federation
Isaeva Anna I.
S. V. Lunyova
Cancer Research Institute, Siberian Branch of the Russian Academy of Medical Sciences, Tomsk
Russian Federation
Lunyova Svetlana V.
Russian Federation
Lunyova Svetlana V.
L. A. Kudyakov
Tomsk Regional Oncology Center, Tomsk
Russian Federation
Kudyakov Lev A.
Russian Federation
Kudyakov Lev A.
L. V. Pikalova
Tomsk Regional Oncology Center, Tomsk
Russian Federation
Pikalova Lidiya V.
Russian Federation
Pikalova Lidiya V.
References
1. Siegel R., Naishadham D., Jemal A. Cancer Statistics, 2013. CA Cancer J. Clin., 2013, vol. 63, no. 1, pp. 11–30.
2. Howlader N., Noone A.M., Krapcho M. et al. SEER cancer statistics review, 1975–2008. URL: http://seer.cancer.gov/csr/1975_2008 (accessed May 14, 2012).
3. Hong Kong Cancer Registry Statistics. Hong Kong cancer registry, Hong Kong. URL: http://www3.ha.org.hk/cancereg/statistics.html#sqs (accessed May 14, 2012).
4. Cancer Research UK. Cancer stats: cancer statistics for the UK. URL: http://info.cancerresearchuk.org/cancerstats/ (accessed May 14, 2012).
5. Nagataki S., Nystrom E. Epidemiology and primary prevention of thyroid cancer. Thyroid, 2002, vol. 12, no. 10, pp. 889–896.
6. Lise M., Franceschi S., Buzzoni C. et al. Changes in the incidence of thyroid cancer between 1991 and 2005 in Italy: a geographical analysis. Thyroid, 2012, vol. 22, no. 1, pp. 27–34.
7. McLeod D.S., Sawka A.M., Cooper D.S. Controversies in primary treatment of low-risk papillary thyroid cancer. Lancet, 2013, Mar., vol. 381, no. 9871, pp. 1046–1057. doi: 10.1016/S0140-6736(12)62205-3. Epub. 2013. Mar. 22.
8. Kaprin A.D., Starinsky V.V., Petrova G.V. The state of the oncological help to the population of Russia in 2012. Moscow, MNIOI named after P.A. Gertsen Publ., 2013. 232 p. (in Russian).
9. Aschebrook-Kilfoy B., Neta G., Brenner A.V. et al. Common genetic variants in metabolism and detoxification pathways and the risk of papillary thyroid cancer. Endocr. Relat. Cancer, 2012, vol. 19, no. 3, pp. 333–344. doi: 10.1530/ERC-11-0372.
10. Barbieri R.B., Bufalo N.E., Secolin R. et al. Evidence that polymorphisms in detoxification genes modulate the susceptibility for sporadic medullary thyroid carcinoma. Eur. J. Endocrinol., 2012, vol. 166, no. 2, pp. 241–245. doi: 10.1530/EJE-11-0843.
11. Moura M.A., Bergmann A., Aguiar S.S., Thuler L.C. The magnitude of the association between smoking and the risk of developing cancer in Brazil: a multicenter study. BMJ Open, 2014, Feb., vol. 4, no. 2. e003736. doi: 10.1136/bmjopen-2013-003736.
12. Guilhen A.C.T., Bufalo N.E., Morari E.C. et al. Role of the N-Acetyltransferase 2 Detoxification system in thyroid cancer susceptibility. Clinical Cancer Research, 2009, vol. 15, no. 1, pp. 406–412.
13. Pal T., Vogl F.D., Chappuis P.O. et al. Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospitalbased study. J. Clin. Endocrinol. Metab., 2001, vol. 86, no. 11, pp. 5307–5312.
14. Davies L., Welch H.G. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA, 2006, vol. 295, no. 18, pp. 2164–67.
15. Reiners C., Demidchik Y., Drozd V. et al. Thyroid cancer ininfants and adolescents after Chernobyl. Minerva Endocrinol., 2008, vol. 33, no. 4, pp. 381–395.
16. Lushnikov Ye.F., Tsyb A.F., Jamasita S. Thyroid cancer in Russia after the Chernobyl accident. Moscow, Medicine Publ., 2006. 128 p. (in Russian).
17. Pavlova T.V., Smirnova Ye.A., Gurevich L.Ye., Pavlov I.A. Archives of Pathology, 2008, vol. 70, no. 4, pp. 10–13 (in Russian).
18. Abrosimov A.Yu., Lushnikov Ye.F., Frank G.A. Archives of Pathology, 2001, vol. 63, no. 4, pp. 3–9 (in Russian).
19. Parshkov Ye.M., Sokolov V.A., Proshin A.D., Stepanenko V.F. Voprosy jendokrinologii, 2004, vol. 50, no. 5, pp. 533–539 (in Russian).
20. Rozhko A.V., Nadyrov E.A., Masyakin V.B. Medicobiological and socio-psychological problems of safety in emergency situations, 2009, no. 1, pp. 29–32 (in Russian).
21. Rozhko A.V., Masyakin V.B., Nadyrov E.A., Aleksanin S.S. Medico-biological and socio-psychological problems of safety in emergency situations, 2009, no. 3, pp. 6–9 (in Russian).
22. Kumar A., Klinge C.M., Goldstein R.E. Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta. Int. J. Oncol., 2010, vol. 36, no. 5, pp. 1067–1080.
23. Rajoria S., Suriano R., Shanmugam A. et al. Metastatic phenotype is regulated by estrogen in thyroid cells. Thyroid, 2010, vol. 20, no. 1, pp. 33–41.
24. Davydov M.I., Aksel' Ye.M. Vestnik RONC im. N.N. Blohina RAMN, 2011, vol. 22, no. 3s, pp. 143–163 (in Russian).
25. Starinsky V.V., Petrova G.V., Grecova O.P. Practical medicine, 2009, vol. 36, no. 4, pp. 102–105 (in Russian).
26. Bulletin of Surgery named after Grekov I.I. 2008, vol. 167, no. 3, pp. 59–62 (in Russian).
27. Chissov V.I., Starinsky V.V., Petrova G.V. Malignant neoplasms in Russia in 2011 (morbidity and mortality). Moscow, MNIOI named after P.A. Gertsen Publ., 2013, 289 p. (in Russian).
28. Ries L.A.G., Harkins D., Krapcho M. et al., eds. SEER cancer statistics review. 1975–2003. Bethesda, MD: National Cancer Institute, 2005 (accessed December 27, 2006, at http://seer. cancer.gov/csr/1975_2003/).
29. Nelson R. Improved detection not only reason for rise in thyroid cancer. Medscape, October 10. URL: www.medscape.com/viewarticle/812433
30. Blom C.B., Ceolin L., Romitti M. et al. The rare intracellular RET mutation p.Ser891Ala in an apparentlysporadic medullary thyroid carcinoma: a case report and review of the literature. Arq. Bras. Endocrinol. Metabol., 2012, vol. 56, no. 8, pp. 586–591.
31. Reshetov I.V., Starinsky V.V., Egorov G.N., Grecova O.P., Petrova G.V. Oncosurgery, 2011, vol. 3, no. 4. pp. 51–54 (in Russian).
32. Bel'tsevich D.G., Gersimenko O.A., Fadeev V.V., Vanushko V.E., Kuznecov N.S., Mel'nichenko G.A. Clinical and Experimental Thyreodology, 2009, vol. 5, no. 3. pp. 3–36 (in Russian).
33. Bacher C., Ricabona C., Totsch M. Incidence and characteristic of thyroid carcinoma after iodine prophylaxis in an endemic goiter country. Thyroid, 1997, vol. 7, no. 5, pp. 733–741.
34. Vigneri R., Pezzino V., Squatrito S. et al. Elimination of iodine dificiency disorders in Central and Eastern Europe, the Commonwealth of Independent States and The Baltic States. WHO/Euro/Nut., 1998, vol. 1, pp. 69–73.
35. Valdina Ye.A. Thyroid disease. St. Petersburg, Piter Publ., 2006. 368 p. (in Russian).
36. Cady B. Studying in thyroid carcinoma. Eur. J. Cancer, 1998, vol. 83, no. 5, pp. 844–847.
37. Barchuk A.S. Practical Oncology, 2007, vol. 8, no. 1 (29), pp. 35–41 (in Russian).
38. Мazzfferi E.L., Jhiang S.М. Long term impact of initial surgical and medical therapy on papillary and follicu lar thyroid cancer. Аm. J. Med., 1994, vol. 97, no. 5, pp. 418–428.
Review
For citations:
Vorozhtsova I.N., Latypova V.N., Saprina T.V., Beryozkina I.S., Zima A.P., Isaeva A.I., Lunyova S.V., Kudyakov L.A., Pikalova L.V. PECULIARITIES AND CHARACTERISTICS OF INDICATORS OF THYROID CANCER AMONG RESIDENTS OF TOMSK AND TOMSK REGION. Bulletin of Siberian Medicine. 2014;13(2):74-81. (In Russ.) https://doi.org/10.20538/1682-0363-2014-2-74-81
Views:
987
Email this article 